Erlotinib plus bevacizumab versus erlotinib alone in patients with EGFR-positive advanced non-squamous non-small-cell lung cancer (NEJ026): interim analysis of an open-label, randomised, multicentre, phase 3 trialHaruhiro Saito, Makoto Maemondo, Ichiro Nakachi et al.|The Lancet Oncology|2019Cited by 636
Characterization of a new SARS-CoV-2 variant that emerged in BrazilMasaki Imai, Tsuguto Fujimoto, Peter Halfmann et al.|Proceedings of the National Academy of Sciences|2021Cited by 87
A phase II study of biweekly paclitaxel and carboplatin in elderly patients with advanced non-small cell lung cancerKenzo Soejima, Tomoko Betsuyaku, Katsuhiko Naoki et al.|Cancer Chemotherapy and Pharmacology|2015Cited by 7
Clinical Characteristics and Therapeutic Outcomes of Metastatic Peritoneal Carcinomatosis in Non-Small-Cell Lung CancerTetsuo Tani, Kenzo Soejima, Ichiro Nakachi et al.|Cancer Management and Research|2021Cited by 7
Abstract 3006: Hyperoxia may be a treatment option for NSCLCJunko Hamamoto, Kenzo Soejima, Hiroyuki Yasuda et al.|Cancer Research|2015Cited by 0